Acute Coronary Syndrome Sri Lanka Audit Project
NCT02893280 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-09-16
Summary
ACSSLAP is the first island wide audit project in Sri Lanka on ACS.
Conditions
- Acute Coronary Syndrome
- Unstable Angina
- Non ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
Interventions
- DRUG
-
aspirin, clopidogrel, statin, enoxaparin, streptokinase
Acute coronary syndrome treatment
Sponsors & Collaborators
-
Ministry of Health, Sri Lanka
collaborator OTHER_GOV -
University of Colombo
lead OTHER
Principal Investigators
-
Priyadarshani Galappatthy, MD · Department of Pharmacology, Faculty of Medicine, University of Colombo
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-07-31
- Completion
- 2016-08-31
Countries
- Sri Lanka
Study Locations
More Related Trials
-
To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
NCT05573958 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)
NCT04298567 ·Status: COMPLETED
-
RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy
NCT02288260 ·Status: COMPLETED
-
Subclinical Cardiovascular Disease in Psoriatic Disease
NCT03228017 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
NCT02293395 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Function in Patients With an Acute Coronary Syndrome
NCT01992484 ·Status: UNKNOWN
-
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
NCT04006288 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Effectiveness Study
NCT01113060 ·Status: UNKNOWN
-
A Polypill for Acute Coronary Syndrome
NCT07032389 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS
NCT03775746 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin vs Clopidogrel After TAVR
NCT05493657 ·Status: RECRUITING ·Phase: NA
-
Warfarin and Antiplatelet Therapy in Chronic Heart Failure
NCT00007683 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
NCT07318155 ·Status: RECRUITING ·Phase: PHASE2
-
Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
NCT04708587 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
NCT02694848 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy
NCT02293928 ·Status: COMPLETED
-
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
NCT02929888 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3